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ABSTRACT
Understanding the interplay between metabolism and ge-
netic regulation is considered key to shed light on the mech-
anisms underlying cancer onset and progression. In this
work, we reconstruct a number of tumor-specific genome-
scale metabolic models and inspect estimated flux profiles
via statistical analysis, characterizing the detailed metabolic
response associated to altered regulation in various tissues.
We thus demonstrate that combining complementary com-
putational techniques it is possible to identify poly-omic
differences and commonalities across cancer types.
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1 INTRODUCTION
Several recent studies have shown how cancer cells present
distinct metabolic hallmarks, such as deregulated uptake of
glucose and amino acids. Even the gene theory of cancer
has been recently object of revision in light of old and new
observations [1]. It is therefore clear that alterations on a
genomic and a metabolic level do not work in isolation, but
rather co-participate in malignant transformation. However,
the precise rewiring in the metabolism of transformed cells
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requires more extensive elucidation. Here, we address this
problem through the investigation of the entire metabolic
states associated to altered genetic regulation in the NCI60
cancer cell line panel, which covers nine different tissues
[2]. By combining genome-scale metabolic models (GSMMs)
and statistical analysis we characterize the corresponding
cross-cancer poly-omic landscape.
2 METHODS
Experimental data sets here employed are transcriptomic
profiles, nutrient uptake rates and proliferation rates for 56
NCI60 cell lines, obtained from previous studies [3, 4]. We
used this data to build and evaluate an array of cell line-
specific GSMMs, starting from the human cell model Recon
2.2 [5]. In this process, a novel version of METRADE [6] was
adopted to (i) transform normalized gene expression profiles
by gene set rules (ii) obtain tumor-specific flux bounds taking
into account both genetic and metabolic uptake constraints.
The estimation of associated flux configurations is conducted
by a regularized flux balance analysis (FBA) optimization
task, as follows:
max
v
w⊤v − σ2 v
⊤v
subject to S v = 0 ,
vlb φ(Θ) ≤ v ≤ vub φ(Θ) .
(1)
Here w is a real vector expressing the contribution of each
reaction to the objective and σ = 10−6 is a regularization
parameter. Moreover, vectors vlb and vub represent native
flux bounds in Recon. These are altered by a factor deter-
mined by the effective gene expression Θ for each reaction,
according to the following map:
φ(Θ) = δ (1 + γ |loд(Θ)|)sдn(Θ−1) . (2)
In this equation γ is a parameter representing the magnitude
with which expression affects reaction rates, while δ is a scal-
ing factor adjusting native flux bounds relatively to uptake
data. The vector Θ is computed starting from gene expres-
sion values and transforming logical gene-protein-reaction
rules into max/min operations [6].
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Figure 1: (a) Comparison between biomass yield predicted
by each cell line-specific GSMM and the corresponding ex-
perimentally measured proliferation rates at the optimal γ
and δ values. (b) Overview of metabolic reactions whose pre-
dicted fluxes significantly correlate with measured cellular
proliferation (1% threshold). For each pathway, number and
fraction of significantly correlated reactions in blue and red,
respectively.
We performed a sensitivity analysis on parametersγ and δ
in Eq. (2) to evaluate the obtained flux profiles. The Pearson
correlation coefficient (PCC) r between predicted cellular
growth and experimentally measured proliferation rate was
computed through Eq. (1) assuming biomass accumulation
as objective. Repeated PCC estimation allowed identifying
optimal γ and δ values across several orders of magnitude.
We carried out FBA using the COBRA toolbox in Matlab [7].
Finally, using the FactoMineR package in R [8] we performed
principal component analysis (PCA) to characterize the cross-
tumor variation at a genome-scale metabolic flux level.
3 RESULTS
As a result of the sensitivity analysis on parameters γ and δ
in Eq. (2), we obtained a PCC peak where r ≃ 0.66, p-value ≃
1.5 · 10−8 (Fig. 1a). We thus inspected the whole flux profiles
of tumor cells by studying their PCC with respect to cellular
proliferation rates. We observed a significant correlation
(threshold 1%) in a number of cancer-associated pathways,
supporting the reliability of our GSMMs and suggesting other
potential mechanisms of tumor growth (Fig. 1b). In particular,
the majority of the cholesterol synthesis pathway emerges
as correlated to proliferation, supporting previous data that
suggest a dependence of patient survival on alterations in
cholesterol homeostasis.
Next, PCA of the flux profiles allowed detecting poly-omic
heterogeneities across the cell lines. As Fig. 2a shows, the
ovarian and renal cell tumors present a markedly distinct
metabolic behavior, almost orthogonal to all other tissues. A
(a) (b)
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Figure 2: (a) Variability across flux profiles relative to differ-
ent tumor types in the first two principal components space.
(b) Distribution of single reaction contributions to first (pur-
ple) and second (light blue) principal components for the
most highly contributing pathways.
closer look at the composition of first principal components
allowed identifying key associated pathways and metabolic
reactions, such as androgen and estrogen metabolism or
dietary fiber binding (Fig. 2b).
4 CONCLUSIONS
In this work, we analyzed the poly-omic configurations of
multiple cancer types through an integrated computational
pipeline and within a comprehensive cross-tumor frame-
work. Our analysis lea to the identification of both variation
and common patterns across the tumors, providing novel
insights in the general cancer molecular landscape. We thus
also showed that the joint application of GSMMs and statis-
tical analysis techniques can help elucidate the mechanisms
underlying cancer development and progression.
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